Cargando…
Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2
BACKGROUND: Genistein has been proved in vitro and in vivo to lower LDLR level. It is also widely consumed and implicated for its anti-atherogenic effects. However, the molecular mechanism by which genistein lowers the LDL level is still unknown. OBJECTIVE: To understand the anti-atherogenic molecul...
Autores principales: | Kartawijaya, Medicia, Han, Hye Won, Kim, Yunhye, Lee, Seung-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876195/ https://www.ncbi.nlm.nih.gov/pubmed/27211318 http://dx.doi.org/10.3402/fnr.v60.31120 |
Ejemplares similares
-
In vitro Evaluation of the Anti-hypercholesterolemic Effect of Lactobacillus Isolates From Various Sources
por: Tjandrawinata, Raymond Rubianto, et al.
Publicado: (2022) -
Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish
por: Cao, Xiufei, et al.
Publicado: (2022) -
The effect of genistein on lipid levels and LDLR, LXRα and ABCG1 expression in postmenopausal women with hyperlipidemia
por: Zhang, Tao, et al.
Publicado: (2019) -
Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance
por: Lebeau, Paul F., et al.
Publicado: (2022) -
Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy
por: Jiang, Xiyuan, et al.
Publicado: (2019)